Novartis has reported slightly lower than expected revenues for the second quarter, coming in at $12.78 billion dollars, a 1% decline from the same period of la 19 July 2022
London-listed drugmaker Hikma Pharmaceuticals (LON: HIK), one of the largest suppliers of generic injectable medicines in the USA, has acquired Custopharm. 28 September 2021
The recent merger of Mylan and Upjohn was one of the biggest in healthcare. But in their rebirth as Viatris (Nasdaq: VTRS), a lesson about the future of the ind 19 February 2021